SAV1 and sarcoma: Alterations in various effectors of the Hippo signaling cascade such as YAP1, LATS2 or SAV1 copy number variations have recently been described in a variety of sarcoma subtypes and point to a major role of aberrant Hippo signals in different soft tissue malignancies6,30.